M K Proteins Ltd

M K Proteins Board Meeting Date

M K Proteins will hold a board meeting on 13 November 2026 to consider unaudited half-yearly results. The trading window stays closed until 15 November 2026.

M K Proteins Other Announcement

Standard quarterly shareholding pattern filing for M. K. Proteins Ltd for the quarter ended September 30, 2026.

M K Proteins Management Change

M. K. Proteins Ltd's shareholders approved the appointment of Ms. Aritika Garg as an Independent Director for a five-year term at the 14th AGM.

M K Proteins Annual General Meeting

M. K. Proteins Limited conducted its 14th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director appointments, and related party transaction approvals.

M K Proteins Other Announcement

M K Proteins Limited is providing the Annual Report for FY 2025-26 to shareholders via web links and QR codes, per Regulation 36(1)(b) of SEBI LODR.

M K Proteins Annual General Meeting

M K Proteins Limited has scheduled its 14th Annual General Meeting for September 30, 2026, and approved the associated notice and directors' report.

M K Proteins Management Change

M K Proteins Limited has appointed Ms. Aritika Garg as a Non-Executive Independent Director effective August 22, 2026.

M K Proteins Board Meeting Outcome

M. K. Proteins Ltd has appointed Ms. Aritika Garg as an Additional Independent Director, subject to approval by the company's shareholders.

M K Proteins Q1 FY27 Results: Net Profit ₹1.4 Cr, Down 60.0% YoY

M K Proteins Ltd reported revenue from operations of ₹115.2 Cr (+0.3% YoY) and net profit of ₹1.4 Cr (-60.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1.4 Cr · -60.0% YoY

M K Proteins Management Change

Ms. Laxmi Mandal has resigned as an Independent Director of M K Proteins Limited. The resignation is effective from August 12, 2026, due to other business obligations.

M K Proteins Board Meeting Date

M. K. Proteins Ltd scheduled a board meeting on August 13, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.

M K Proteins Q4 FY26 Results: Net Profit ₹1.1 Cr, Down 60.7% YoY

M K Proteins Ltd reported revenue from operations of ₹145.9 Cr (+6.3% YoY) and net profit of ₹1.1 Cr (-60.7% YoY) for Q4 FY26.

Key figure

Net profit ₹1.1 Cr · -60.7% YoY

M K Proteins Financial Results

M. K. Proteins reported its audited standalone financial results for the year ended March 31, 2026. The board also re-appointed cost and internal auditors for FY 2026-27.

M K Proteins Other Announcement

M. K. Proteins submitted its FY2026 Annual Secretarial Compliance Report. The auditor confirmed adherence to SEBI regulations, including Structured Digital Database maintenance.

M K Proteins Board Meeting Date

M. K. Proteins Limited scheduled a board meeting on May 29, 2026, to approve audited financial results. The meeting will also consider auditor re-appointments for FY 2026-27.

M K Proteins Debt & Borrowing: ₹36.19 Cr

M K Proteins Limited confirmed it is not classified as a 'Large Corporate' as of March 31, 2026, under SEBI norms. The company reported outstanding borrowings of ₹36.19 Crore and maintains a CRISIL 'A' credit rating for bank facilities. This disclosure is part of routine regulatory compliance regarding debt market borrowing frameworks.

Value

₹36.19 Cr